| NCT ID | NCT05632406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida State University |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-10-25 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2023-10-25 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine the effect of obesity on cardiovascular responses during various breathing maneuvers.
Eligibility Criteria
Inclusion Criteria: • Body mass index values of ≤40 kg/m\^2 Exclusion Criteria: * Not weight stable (\<5% change in body mass over the past six months) * Overt cardiovascular, neurological, renal, liver, and/or metabolic illness (e.g., diabetes mellitus) * Current, or history of uncontrolled, Stage 2 hypertension (blood pressure \>140 / 90 mmHg; anti-hypertensive medications are permitted) * Diagnosed obstructive sleep apnea * Previous bariatric surgery * Diagnosis or signs (e.g., values below the lower limit of normal) of overt airway disease(s) * Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes, vaping) * Per the POWERbreathe® company: * Patients who have undergone recent abdominal surgery and those with abdominal hernia. * Asthma patients who have a very low symptom perception and suffer from frequent, severe exacerbations or with an abnormally low perception of dyspnoea. * If a patient is suffering from a ruptured eardrum or any other condition of the ear. * Patients with marked elevated left ventricular end-diastolic volume and pressure. * Patients with worsening heart failure signs and symptoms after a respiratory/inspiratory muscle training (IMT) session * If you are suffering from a cold, sinusitis, or respiratory tract infection, we advise that you do not use your POWERbreathe IMT device. * Individuals who are not yet adults (infants, children, teenagers) * Pregnant (self-reported and urine pregnancy test conducted), lactating (self-reported), or post-menopausal (self-reported) females * Prisoners
Contact & Investigator
Joseph Watso, PhD
PRINCIPAL INVESTIGATOR
Florida State University
Frequently Asked Questions
Who can join the NCT05632406 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05632406 currently recruiting?
Yes, NCT05632406 is actively recruiting participants. Contact the research team at jwatso@fsu.edu for enrollment information.
Where is the NCT05632406 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT05632406 clinical trial?
NCT05632406 is sponsored by Florida State University. The principal investigator is Joseph Watso, PhD at Florida State University. The trial plans to enroll 80 participants.